Diana Tucker

Diana Tucker is the CEO and Co-Founder of SenoGuard, a medical device startup developing an innovative alternative to radiation therapy following breast-conserving surgery for early-stage breast cancer. With more than 25 years of experience in the medical device and diagnostics industry, Diana has built a career at the intersection of strategic marketing, product commercialization, and market intelligence. She has held senior leadership roles at companies such as Agendia, where she drove significant revenue and market share growth, and founded Medical Market Intelligence, advising emerging healthcare companies on bringing paradigm-shifting technologies to market.

A Pepperdine MBA and UC Irvine graduate in Molecular and Cellular Biology, Diana combines deep scientific understanding with a proven track record in business strategy and market development. She is recognized for her expertise in medical device marketing, due diligence, and trend analysis, serving as a council member for GLG-Gerson Lehrman Group. Through SenoGuard and her advisory work, Diana remains committed to advancing patient care by accelerating the adoption of breakthrough medical innovations.

CEO and Founder of SenoGuard